Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung

BMC Research Notes

Table 1 Procalcitonin expression and the tumor response

Case No.	Pathology	Sampling procedure	Intensity score	Proportion score	Total IHCscore	Expressionof PCT	Serum PCT (ng/mL)	Serum CRP (mg/dL)	Metastasis
1	LCNEC	Surgery	1	0	1	Low	0.05	4.17	–
2	LCNEC	Surgery	2	1	3	High	0.07	0.08	Br
3	LCNEC	Surgery	0	0	0	-	0.08	1.16	–
4	LCNEC	Surgery	0	0	0	-	N/D	< 0.02	–
5	LCNEC	Surgery	0	0	0	-	0.14	11.20	–
6	LCNEC	Surgery	0	0	0	-	0.03	0.04	–
7	LCNEC	Surgery	2	4	6	High	170.4	2.05	Br, Ad
8	LCNEC	Surgery	0	0	0	-	0.06	6.00	-
9	LCNEC	Surgery	2	4	6	High	16.72	1.90	Br, Bo, Pl
10	LCNEC	Surgery	1	0	1	Low	0.03	0.07	–
11	Carcinoid	Surgery	2	4	6	High	0.35	19.26	–
12	Carcinoid	Surgery	0	0	0	-	N/E	0.09	–
13	Carcinoid	Surgery	2	0	2	Low	0.03	< 0.02	–
14	Carcinoid	Surgery	0	0	0	-	N/E	< 0.02	–
15	SCLC	Surgery	0	0	0	-	0.07	2.80	–
16	SCLC	Bronchoscopy	0	0	0	-	0.24	2.89	–
17	SCLC	Bronchoscopy	0	0	0	-	0.03	0.06	–
18	SCLC	Bronchoscopy	0	0	0	-	0.07	3.04	–
19	SCLC	Bronchoscopy	0	0	0	-	0.04	3.05	–
20	SCLC	Bronchoscopy	0	0	0	-	0.05	0.04	–
21	SCLC	Bronchoscopy	0	0	0	-	N/D	0.09	Br

N/D not detected, N/E not examined, Br brain, Ad adrenal gland, Bo bone, Pl pleura

ISSN: 1756-0500